DK0541692T3 - Herpes simplex virus VP-16-vacciner - Google Patents
Herpes simplex virus VP-16-vaccinerInfo
- Publication number
- DK0541692T3 DK0541692T3 DK91914945T DK91914945T DK0541692T3 DK 0541692 T3 DK0541692 T3 DK 0541692T3 DK 91914945 T DK91914945 T DK 91914945T DK 91914945 T DK91914945 T DK 91914945T DK 0541692 T3 DK0541692 T3 DK 0541692T3
- Authority
- DK
- Denmark
- Prior art keywords
- herpes simplex
- simplex virus
- vaccines
- compositions
- hsv
- Prior art date
Links
- 241000700584 Simplexvirus Species 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 208000009889 Herpes Simplex Diseases 0.000 abstract 1
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56152890A | 1990-08-02 | 1990-08-02 | |
PCT/US1991/005403 WO1992002251A1 (en) | 1990-08-02 | 1991-07-30 | Herpes simplex virus vp16 vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0541692T3 true DK0541692T3 (da) | 1999-11-01 |
Family
ID=24242345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91914945T DK0541692T3 (da) | 1990-08-02 | 1991-07-30 | Herpes simplex virus VP-16-vacciner |
Country Status (12)
Country | Link |
---|---|
US (2) | US5714152A (da) |
EP (1) | EP0541692B1 (da) |
JP (3) | JP3005292B2 (da) |
AT (1) | ATE179614T1 (da) |
CA (1) | CA2088600C (da) |
DE (1) | DE69131200T2 (da) |
DK (1) | DK0541692T3 (da) |
ES (1) | ES2134197T3 (da) |
GR (1) | GR3030834T3 (da) |
IE (1) | IE912744A1 (da) |
PT (1) | PT98565B (da) |
WO (1) | WO1992002251A1 (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
GB9119940D0 (en) * | 1991-09-18 | 1991-10-30 | Hare Peter F J O | Polypeptide inhibitor of viral replication |
US5965354A (en) * | 1995-07-28 | 1999-10-12 | Chiron Corporation | Herpes simplex virus diagnostics |
US5980912A (en) * | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
EP0984790A1 (en) | 1997-06-02 | 2000-03-15 | Chiron Corporation | Herpes simplex virus vp22 vaccines and methods of use |
US6087166A (en) * | 1997-07-03 | 2000-07-11 | Basf Aktiengesellschaft | Transcriptional activators with graded transactivation potential |
DE69933200T2 (de) * | 1998-03-09 | 2007-02-22 | Glaxosmithkline Biologicals S.A. | Kombinierte impfstoffzusammensetzungen |
KR20010085348A (ko) | 1998-08-07 | 2001-09-07 | 추후보정 | 면역능을 갖는 헤르페스 심플렉스 바이러스 항원 및 이를이용하는 방법 |
US6860615B2 (en) * | 1999-01-06 | 2005-03-01 | Armament Systems And Procedures, Inc. | LED flashlight with integral keyring clip |
US6569616B1 (en) * | 1999-07-29 | 2003-05-27 | Wisconsin Alumni Research Foundation | Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate |
JP2003512305A (ja) | 1999-09-30 | 2003-04-02 | ユニバーシティ オブ ワシントン | 免疫学的に重要な単純疱疹ウイルス抗原 |
ATE488249T1 (de) | 2001-07-31 | 2010-12-15 | Univ Washington | Immunologisch bedeutende herpes-simplex-virus- antigene und verfahren für ihre verwendung |
KR100420501B1 (ko) * | 2001-09-26 | 2004-03-02 | 한국지질자원연구원 | 벤토나이트로부터 몬모릴로나이트 광물의 분리·회수 방법 |
CA2486553C (en) * | 2002-06-17 | 2012-01-10 | Taro Pharmaceuticals U.S.A., Inc. | Ibuprofen suspension |
AU2004274430A1 (en) | 2003-09-12 | 2005-03-31 | Antigenics, Inc. | Vaccine for treatment and prevention of herpes simplex virus infection |
US8460674B2 (en) | 2009-02-07 | 2013-06-11 | University Of Washington | HSV-1 epitopes and methods for using same |
US9044447B2 (en) | 2009-04-03 | 2015-06-02 | University Of Washington | Antigenic peptide of HSV-2 and methods for using same |
MY159500A (en) * | 2009-05-22 | 2017-01-13 | Genocea Biosciences Inc | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
WO2012074881A2 (en) | 2010-11-24 | 2012-06-07 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
WO2013078299A1 (en) | 2011-11-23 | 2013-05-30 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
JP2019537555A (ja) | 2016-09-28 | 2019-12-26 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | ヘルペスを処置するための方法および組成物 |
US10745931B1 (en) | 2019-08-14 | 2020-08-18 | Premises Innovations Llc | Self-rightening post system |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4818694A (en) * | 1982-07-20 | 1989-04-04 | American Cyanamid Company | Production of herpes simplex viral protein |
US4891315A (en) * | 1982-10-25 | 1990-01-02 | American Cyanamid Company | Production of herpes simplex viral porteins |
AU1678783A (en) * | 1982-07-20 | 1984-01-26 | Molecular Genetics, Inc. | Production of herpes simplex viral proteins |
DE3461928D1 (en) * | 1983-06-23 | 1987-02-12 | Person Stanley | Immunologically reactive non-glycosylated amino acid chains of glycoprotein b of herpes virus types 1 and 2 |
NZ209308A (en) * | 1983-08-30 | 1991-08-27 | Genentech Inc | Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein |
JPS6051120A (ja) * | 1983-08-31 | 1985-03-22 | Chemo Sero Therapeut Res Inst | 単純ヘルペスサブユニットワクチン |
US4642333A (en) * | 1983-09-16 | 1987-02-10 | Stanley Person | Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2 |
US4855224A (en) * | 1984-03-09 | 1989-08-08 | Genentech, Inc. | Molecularly cloned diagnostic product and method of use |
US4618578A (en) * | 1984-07-17 | 1986-10-21 | Chiron Corporation | Expression of glycoprotein D of herpes simplex virus |
US5171568A (en) * | 1984-04-06 | 1992-12-15 | Chiron Corporation | Recombinant herpes simplex gb-gd vaccine |
ATE230798T1 (de) * | 1984-04-06 | 2003-01-15 | Chiron Corp | Rekombinanter herpes simplex gb-gd-impfstoff |
FR2563434B1 (fr) * | 1984-04-25 | 1986-07-25 | Transgene Sa | Vaccin contre la rage et procede pour sa preparation |
US4859587A (en) * | 1984-06-04 | 1989-08-22 | Institut Merieux | Recombinant herpes simplex viruses, vaccines and methods |
JPH0668B2 (ja) * | 1985-08-30 | 1994-01-05 | 財団法人化学及血清療法研究所 | 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド |
ATE136468T1 (de) * | 1986-10-20 | 1996-04-15 | Chiron Corp | Impfstoff zur behandlung von hsv |
GB8917029D0 (en) * | 1989-07-25 | 1989-09-13 | Marie Curie Memorial Foundatio | Polypeptide inhibitor of viral replication |
-
1991
- 1991-07-30 EP EP91914945A patent/EP0541692B1/en not_active Expired - Lifetime
- 1991-07-30 WO PCT/US1991/005403 patent/WO1992002251A1/en active IP Right Grant
- 1991-07-30 ES ES91914945T patent/ES2134197T3/es not_active Expired - Lifetime
- 1991-07-30 AT AT91914945T patent/ATE179614T1/de not_active IP Right Cessation
- 1991-07-30 CA CA002088600A patent/CA2088600C/en not_active Expired - Fee Related
- 1991-07-30 DK DK91914945T patent/DK0541692T3/da active
- 1991-07-30 JP JP3514486A patent/JP3005292B2/ja not_active Expired - Fee Related
- 1991-07-30 DE DE69131200T patent/DE69131200T2/de not_active Expired - Fee Related
- 1991-08-01 IE IE274491A patent/IE912744A1/en not_active Application Discontinuation
- 1991-08-02 PT PT98565A patent/PT98565B/pt not_active IP Right Cessation
-
1994
- 1994-10-13 US US08/322,729 patent/US5714152A/en not_active Expired - Fee Related
-
1995
- 1995-05-17 US US08/442,980 patent/US5795579A/en not_active Expired - Fee Related
-
1999
- 1999-03-23 JP JP11078661A patent/JPH11308998A/ja not_active Withdrawn
- 1999-07-21 GR GR990401924T patent/GR3030834T3/el unknown
-
2001
- 2001-09-10 JP JP2001274335A patent/JP2002136297A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GR3030834T3 (en) | 1999-11-30 |
WO1992002251A1 (en) | 1992-02-20 |
JP2002136297A (ja) | 2002-05-14 |
EP0541692B1 (en) | 1999-05-06 |
DE69131200D1 (en) | 1999-06-10 |
EP0541692A4 (en) | 1993-12-08 |
PT98565A (pt) | 1992-06-30 |
CA2088600C (en) | 1999-11-16 |
EP0541692A1 (en) | 1993-05-19 |
DE69131200T2 (de) | 1999-12-09 |
JPH06502989A (ja) | 1994-04-07 |
IE912744A1 (en) | 1992-02-12 |
ES2134197T3 (es) | 1999-10-01 |
US5795579A (en) | 1998-08-18 |
US5714152A (en) | 1998-02-03 |
JP3005292B2 (ja) | 2000-01-31 |
ATE179614T1 (de) | 1999-05-15 |
CA2088600A1 (en) | 1992-02-03 |
JPH11308998A (ja) | 1999-11-09 |
PT98565B (pt) | 1999-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0541692T3 (da) | Herpes simplex virus VP-16-vacciner | |
ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
NL300185I1 (nl) | Acellulair vaccin. | |
NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
IL104780A0 (en) | Sulfonic acid derivatives in the treatment of viral diseases | |
ATE190659T1 (de) | Rekombinante immuntoxine | |
DK0909323T3 (da) | Helicobacter pylori-bakterioferritin | |
ATE220557T1 (de) | Darmprotozoen-impfstoffe | |
DK0545991T3 (da) | Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf | |
DK0459176T3 (da) | Oligophosphater med antiviral virkning | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов | |
MX9400210A (es) | Tratamiento de infecciones virales. |